04.11.2014 Views

cyckV4

cyckV4

cyckV4

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

734 REQUIREMENTS FOR PATENT PROTECTION: NOVELTY<br />

glucosinolates and high in Phase 2 enzyme-inducing potential. Atlas Powder, 190 F.3d at<br />

1348 (“The public remains free to make, use, or sell prior art compositions or processes,<br />

regardless of whether or not they understand their complete makeup [or] the underlying<br />

scientific principles which allow them to operate.”). . . .<br />

In summary, the prior art inherently contains the claim limitations that Brassica<br />

relies upon to distinguish its claims from the prior art. While Brassica may have<br />

recognized something about sprouts that was not known before, Brassica’s claims do not<br />

describe a new method.<br />

CONCLUSION<br />

For the foregoing reasons, we affirm the district court’s summary judgment that<br />

the claims at issue are anticipated by the prior art. The prior art indisputably includes<br />

growing, harvesting and eating particular sprouts which Brassica has recognized as being<br />

rich in glucosinolates and high in Phase 2 enzyme-inducing potential. But the<br />

glucosinolate content and Phase 2 enzyme-inducing potential of these sprouts are<br />

inherent properties of the sprouts put there by nature, not by Brassica. Brassica simply<br />

has not claimed anything that is new and its claims are therefore invalid.<br />

AFFIRMED.<br />

Questions:<br />

1.) We admit to putting this case in the book partly because we love its name but it also<br />

raises some fascinating questions about novelty. The crux with novelty is whether the<br />

public had access to the benefit provided by the innovation. Did they here? Yes, they had<br />

sprouts. And yes, if they ate sprouts, at the right moment in their development, then they<br />

got the benefit of the anti-carcinogens. But they did not know that eating sprouts at that<br />

stage provided those benefits. So why claim that the claims were anticipated, that is, that<br />

they were not novel?<br />

2.) Does this passage, approvingly quoted from another case, suggest some of the court’s<br />

concerns?<br />

“The public remains free to make, use, or sell prior art compositions or<br />

processes, regardless of whether or not they understand their complete<br />

makeup or the underlying scientific principles which allow them to<br />

operate.” . . .<br />

3.) What is the concept of “inherency” and how is it used here?<br />

5.) Statutory Bar: Public Use<br />

Pennock v. Dialogue<br />

27 U.S. 1 (1829)<br />

This case was brought before the Court, on a writ of error to the circuit court for<br />

the eastern district of Pennsylvania.<br />

In that court, the plaintiffs in error had instituted their suit against the defendants,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!